First National Bank of South Miami’s GSK GSK Stock Holding History

First National Bank of South Miami’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$25.8K	Sell	725 -228	-24%	-$8.18K	0.02%	201
2023 Q1	$33.9K	Sell	953 -424	-31%	-$14.8K	0.03%	205
2022 Q4	$49K	Buy	+1,377	New	+$45.9K	0.04%	190
2022 Q3	–	Sell	-1,379	Closed	-$75K	–	276
2022 Q2	$75K	Hold	1,379	–	–	0.05%	183
2022 Q1	$75K	Hold	1,379	–	–	0.05%	199
2021 Q4	$76K	Hold	1,379	–	–	0.05%	197
2021 Q3	$66K	Hold	1,379	–	–	0.04%	190
2021 Q2	$69K	Hold	1,379	–	–	0.05%	189
2021 Q1	$62K	Hold	1,379	–	–	0.05%	176
2020 Q4	$64K	Sell	1,379 -131	-9%	-$6.02K	0.06%	172
2020 Q3	$71K	Sell	1,510 -766	-34%	-$38.4K	0.07%	158
2020 Q2	$116K	Hold	2,276	–	–	0.13%	128
2020 Q1	$108K	Hold	2,276	–	–	0.14%	124
2019 Q4	$134K	Hold	2,276	–	–	0.13%	122
2019 Q3	$118K	Hold	2,276	–	–	0.11%	135
2019 Q2	$117K	Sell	2,276 -918	-29%	-$46.1K	0.11%	137
2019 Q1	$167K	Hold	3,194	–	–	0.16%	116
2018 Q4	$157K	Buy	+3,194	New	+$157K	0.15%	118

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First National Bank of South Miami's GSK Position: Q2 2023 in Review

First National Bank of South Miami reduced its GSK (GSK) stake by 24% in Q2 2023, selling an estimated $8.18K and leaving 725 shares worth $25.8K. The position accounts for 0.02% of the portfolio, ranked #201.

First National Bank of South Miami first reported a position in GSK in Q4 2018 and has held it in 18 quarters since. The position peaked at $167K in Q1 2019. 828 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

First National Bank of South Miami held 725 shares of GSK worth $25.8K as of Q2 2023.
First National Bank of South Miami sold 228 GSK shares in Q2 2023, an estimated $8.18K.
GSK made up 0.02% of First National Bank of South Miami's portfolio in Q2 2023, its #201 holding.
First National Bank of South Miami first reported a position in GSK in Q4 2018 and has held it in 18 quarters since.
First National Bank of South Miami's GSK position peaked at $167K in Q1 2019.
828 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.